Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
The Journal of Pediatrics|September 22, 2015
Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung FunctionWayne J Morgan, Donald R VanDevanter, David J Pasta, et al.Journal of Clinical Microbiology|December 25, 2015
Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory SpecimensMona A Mahboubi, Lisa A Carmody, Bridget K Foster, et al.Pediatric Pulmonology|July 4, 2017
Comparison of FEV<sub>1</sub> reference equations for evaluating a cystic fibrosis therapeutic interventionMichael W Konstan, Jeffrey S Wagener, Donald R VanDevanter, et al.Pediatric Pulmonology|November 21, 2019
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosisJeffrey S Wagener, Donald R VanDevanter, Michael W Konstan, et al.Annals of the American Thoracic Society|March 22, 2017
Relationship of Antibiotic Treatment to Recovery after Acute FEV<sub>1</sub> Decline in Children with Cystic FibrosisWayne J Morgan, Jeffrey S Wagener, David J Pasta, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2012
Risk factors for rate of decline in FEV1 in adults with cystic fibrosisMichael W Konstan, Jeffrey S Wagener, Donald R Vandevanter, et al.Pediatric Pulmonology|August 19, 2010
Trends in the use of routine therapies in cystic fibrosis: 1995-2005Michael W Konstan, Donald R VanDevanter, Lawrence Rasouliyan, et al.Pediatric Pulmonology|August 19, 2010
Pulmonary outcome prediction (POP) tools for cystic fibrosis patientsDonald R VanDevanter, Jeffrey S Wagener, David J Pasta, et al.Pediatric Pulmonology|August 31, 2004
Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung diseaseTimothy D Murphy, Ran D Anbar, Lucille A Lester, et al.Pediatric Pulmonology|September 11, 2013
Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infectionCarlos E Milla, James F Chmiel, Frank J Accurso, et al.Pageof 8